-Robert Snoeck Researcher Activity Profile

Research Author Detailed Information 

Robert Snoeck Publication Rate By Year

Robert Snoeck has published 25 paper(s) in 2007, 2 paper(s) in 2008, for a total of 27 research publications in total.

Robert R Snoeck Author Information

LAST NAME: snoeck

FIRST NAME: robert

INITIALS: R

AFFILIATION:

Papers

Robert Snoeck's Publication Record

1. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA. Year Published: 2007
Rega Institute for Medical Research, K.U.Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
2. Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds. Year Published: 2007
Gilead Sciences & IOCB Research Centre, Centre for New Antivirals and Antineoplastics (IOCB), Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic. marcela@uochb.cas.cz
3. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains. Year Published: 2007
Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, Leuven, Belgium.
4. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV). Year Published: 2007
5. Ester prodrugs of cyclic 1-(S)- [3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity. Year Published: 2007
Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic. marcela@uochb.cas.cz
6. Activities of Several Classes of Acyclic Nucleoside Phosphonates against Camelpox Virus Replication in Different Cell Culture Models. Year Published: 2007
Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, Leuven, Belgium. Robert.Snoeck@rega.kuleuven.be.
7. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus. Year Published: 2007
Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3XF, UK.
8. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV). Year Published: 2007
9. Alkyne-azide click chemistry mediated carbanucleosides synthesis. Year Published: 2007
10. Cross-metathesis mediated synthesis of new acyclic nucleoside phosphonates. Year Published: 2007
11. Novel non-nucleoside human cytomegalovirus inhibitors based upon tsao nucleoside derivatives: structure-activity relationships. Year Published: 2007
12. Synthesis and Antiviral Activity of the Carbocyclic Analogue of the Highly Potent and Selective Anti-VZV Bicyclo Furano Pyrimidines. Year Published: 2007
mcguigan@cardiff.ac.uk.
13. Alkyne-azide click chemistry mediated carbanucleosides synthesis. Year Published: 2007
14. Cross-metathesis mediated synthesis of new acyclic nucleoside phosphonates. Year Published: 2007
15. Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. Year Published: 2007
16. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Year Published: 2007
Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, Leuven, Belgium.
17. Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity. Year Published: 2007
Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic. marcela@uochb.cas.cz
18. Alkyne-azide click chemistry mediated carbanucleosides synthesis. Year Published: 2007
19. Cross-metathesis mediated synthesis of new acyclic nucleoside phosphonates. Year Published: 2007
20. Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. Year Published: 2007
21. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus. Year Published: 2007
Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff CF10 3XF, UK. mcguigan@cardiff.ac.uk
22. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV). Year Published: 2007
23. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines. Year Published: 2007
Welsh School of Pharmacy, Cardiff University, UK.
24. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Year Published: 2008
Rega Institute For Medical Research, KU Leuven, Leuven, Belgium.
25. Novel inhibitors of human CMV. Year Published: 2008
Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, KU Leuven, Belgium. robert.snoeck@rega.kuleuven.ac.be.
26. Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. Year Published: 2007
Instituto de Química Médica (CSIC), Madrid, Spain.
27. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines. Year Published: 2007
Welsh School of Pharmacy, Cardiff University, UK.